Genetically defined hyperlipidemia

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.5, Iss.3, 2004-04, pp. : 295-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetically defined pancreatic beta cell failure

By Smit Jan WA Diamant Michaela

Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. : 669-678

Future Medicine

Access to resources Recommend Favorite

Metabolism of Lidocaine in Primary Hyperlipidemia

By Różański J. Wójcicki J. Gawrońska-Szklarz B. Musial H.D. Millo B. Dutkiewicz G.

Pharmacology Communications, Vol. 12, Iss. 3, 2002-07 ,pp. : 179-187

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacokinetics of phenytoin in hyperlipidemia

By Dutkiewicz G. Wojcicki J. Gawronska-Szklarz B.

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 1, 1996-01 ,pp. : 33-37

Elsevier

Access to resources Recommend Favorite

Drug Treatment of Combined Hyperlipidemia

By Wierzbicki A.S.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. : 327-336

Adis International

Access to resources Recommend Favorite

Emerging drugs for hyperlipidemia

By Paras Christos Hussain M Mahmood Rosenson Robert S

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 433-451

Informa Healthcare

Access to resources Recommend Favorite